Stocks Rise as Earnings, Vaccine Developments Hit

Name: Stocks Rise as Earnings, Vaccine Developments Hit
Uploaded: 2020-10-20T13:59:14+00:00
Duration: P146S
Description: Moderna CEO Stephane Bancel said the U.S. government could authorize emergency use of the company's experimental Covid-19 vaccine by December.

Video Credit: The Street - Duration: 02:26s - Published on October 20, 2020

Stocks Rise as Earnings, Vaccine Developments Hit

Moderna CEO Stephane Bancel said the U.S. government could authorize emergency use of the company's experimental Covid-19 vaccine by December.

0 shares	Share Tweet Save Post Send

Related videos from verified sources

Moderna Gets a Shot From Pre-Sales of its Covid-19 Vaccine [Video]

Moderna Gets a Shot From Pre-Sales of its Covid-19 Vaccine

Moderna third-quarter earnings fall but sales jump as governments around the world place pre-orders for its yet-to-be approved Covid-19 vaccine candidate.

Credit: The Street Duration: 02:15Published on October 29, 2020

Stocks end mixed; Microsoft tops sales forecast [Video]

Stocks end mixed; Microsoft tops sales forecast

The Dow and S&P 500 fell on lackluster earnings, election worries and rising COVID-19 cases worldwide, but tech stocks fared better and had positive news after the close when Microsoft topped sales..

Credit: Reuters Studio Duration: 01:41Published on October 27, 2020

Trouble for markets, if tech earnings disappoint: Kramer [Video]

Trouble for markets, if tech earnings disappoint: Kramer

Hilary Kramer, CIO of Kramer Capital Research, joins Yahaira Jacquez to discuss stocks on Wall Street falling sharply on Monday and her take on tech earnings coming up this week.

Credit: Reuters Studio Duration: 05:55Published on October 26, 2020

Stocks Rise as Earnings, Vaccine Developments Hit

You Might Like

Related videos from verified sources